PK/PD of XM22 in Children With Ewing Family of Tumors or Rhabdomyosarcoma

This study is currently recruiting participants.
Verified March 2014 by Teva Pharmaceutical Industries
Sponsor:
Information provided by (Responsible Party):
Teva Pharmaceutical Industries ( Merckle GmbH )
ClinicalTrials.gov Identifier:
NCT01585649
First received: April 18, 2012
Last updated: March 20, 2014
Last verified: March 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: July 2014
  Estimated Primary Completion Date: June 2014 (Final data collection date for primary outcome measure)